Hepatitis C Found to Up Odds for Certain Head and Neck Cancers

This article originally appeared here.
Share this content:
Hepatitis C Found to Up Odds for Certain Head and Neck Cancers
Hepatitis C Found to Up Odds for Certain Head and Neck Cancers

THURSDAY, April 14, 2016 (HealthDay News) -- Hepatitis C may increase the risk for certain types of head and neck cancers, according to a study published online April 13 in the Journal of the National Cancer Institute.

Harrys Torres, M.D., an associate professor of infectious diseases at the University of Texas MD Anderson Cancer Center in Houston, and colleagues analyzed data from 34,545 patients tested at the medical center.

The researchers found that those with hepatitis C appeared to have more than twice the risk for cancers of the oral cavity and oropharynx (2.40 and 2.04 times, respectively), and a nearly five-fold higher risk for cancers of the larynx (4.96 times), compared to those without hepatitis C. The researchers also found that head and neck cancer patients with hepatitis C were more likely to have human papillomavirus.

"Obviously, a hepatitis C infection could impact how patients respond to their cancer therapy. We also realized that many of our hepatitis patients were excluded from clinical trials," Torres said in an MD Anderson news release. "Now that many with hepatitis C can be cured, it is important that we first address and potentially cure the virus, so that they can have access to necessary cancer therapy."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths